Clinical Trial Investigative Site Network Market Report 2025

The clinical trial investigative site network market size has grown strongly in recent years. It will grow from $8.01 billion in 2024 to $8.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historical period can be attributed to the increasing prevalence of chronic and infectious diseases, the globalization of clinical trials, expansion in oncology, growth of the pharmaceutical sector, and rising government funding for clinical research.

The clinical trial investigative site network market size is expected to see strong growth in the next few years. It will grow to $12.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The projected growth during the forecast period can be attributed to increased investment in adaptive and precision clinical trial designs, expanding collaborations between pharmaceutical companies and clinical site networks, broadening of therapeutic areas beyond oncology, a rising number of adaptive and platform trials, and a growing pipeline of biologics and personalized medicines. Key trends expected in this period include the adoption of unified digital platforms, AI-driven patient recruitment tools, facilitation of decentralized clinical trials (DCT), use of blockchain for data integrity and transparency, and the development of cloud-based site management systems.

The growing demand for clinical research activity is expected to drive the expansion of the clinical trial investigative site network market. Clinical research activity involves organized efforts to design and analyze clinical studies aimed at advancing medical knowledge or public health. This demand is fueled by the increasing need for innovative therapies to treat chronic and complex diseases, prompting intensified development of safe and effective drugs and medical devices through thorough clinical trials. Clinical trial investigative site networks support these activities by enabling centralized coordination, faster implementation, and consistent quality control across multiple trial sites. For example, in December 2024, the National Library of Medicine (NLM), a US-based biomedical library, reported 520,884 registered clinical trials worldwide, up significantly from about 477,207 in mid-2023. This nearly 20% increase in just over a year highlights sustained and strong growth in global clinical research efforts. As a result, the rising demand for clinical research activity is fueling the growth of the clinical trial investigative site network market.

Key players in the clinical trial investigative site network market are focusing on launching innovative platforms such as single sign-on systems to streamline site operations, improve data access, and boost trial efficiency. Single sign-on platforms enable users to access multiple applications with a single set of login credentials, simplifying access, enhancing security, and reducing the burden of managing multiple logins. For instance, in June 2024, IQVIA Inc., a US-based clinical research and health technology company, introduced One Home for Sites, a unified clinical trial platform designed to simplify site workflows and improve efficiency. The platform offers single sign-on access to multiple trial systems, centralized study dashboards for better trial oversight, and integrated communication tools to facilitate collaboration among sponsors, CROs, and site teams. Additionally, it supports automated workflows, document management, and real-time performance analytics, helping sites reduce administrative complexity, maintain regulatory compliance, and accelerate trial execution with greater transparency.

In January 2025, Medical Research Network (MRN), a UK-based clinical trial acceleration company, acquired Volunteer Centre for Trials & Clinical Research (VCTC) for an undisclosed sum. This acquisition aims to expand MRN’s presence in the UK and enhance its global community-based clinical trial capabilities by incorporating VCTC's multi-therapeutic site network and advancing virtual trial delivery models. VCTC is a UK-based clinical trial site network specializing in patient-focused and decentralized clinical research solutions.

Major players in the clinical trial investigative site network market are IQVIA Inc., ICON plc, SGS Société Générale de Surveillance SA., Fortrea Holdings Inc., Medpace Holdings Inc., ClinChoice Inc., Velocity Clinical Research Inc., NVISION Clinical Research LLC, George Clinical, Medical Research Network Limited, MAC Clinical Research Ltd., FOMAT Medical Research Inc., Clara Health Inc., WCG Clinical, Access Clinical Trials Inc., KV Clinical Research, SMO-Pharmina, Clinical Research Network LLC, CenExel Clinical Research, EMS Healthcare Ltd.

North America was the largest region in the clinical trial investigative site network market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial investigative site network report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical trial investigative site network market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial investigative site network market consists of revenues earned by entities by providing services such as patient recruitment and enrollment, study conduct and management, data collection and management, site monitoring and quality assurance, and patient care and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial investigative site network market also includes sales of clinical trial data management systems, patient recruitment tools, standardized protocol templates, electronic case report forms and monitoring and reporting tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The clinical trial investigative site network market research report is one of a series of new reports that provides clinical trial investigative site network market statistics, including the clinical trial investigative site network industry global market size, regional shares, competitors with the clinical trial investigative site network market share, detailed clinical trial investigative site network market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial investigative site network industry. This clinical trial investigative site network market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A clinical trial investigative site network is a collective of clinical research sites that work together within a unified system to conduct clinical trials. These networks enhance study execution by offering standardized protocols, centralized oversight, and expedited patient recruitment across multiple locations.

The main types of clinical trials conducted within these networks include interventional trials, observational trials, expanded access trials, and adaptive trials. Interventional trials involve researchers actively assigning participants to specific treatments or interventions to assess their impact on health outcomes. Typical site types encompass academic medical centers, community hospitals, specialized research institutions, private practices, and site management organizations (SMOs). These trials cover a broad range of applications such as oncology, cardiology, central nervous system disorders, pain management, endocrine disorders, and more. The primary end-users include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and other healthcare organizations.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.